- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05319717
Rice Bran-based Supplemental Foods for the Treatment of Childhood Malnutrition
Rice Bran in Ready-to-use Therapeutic Foods for Microbiota-targeted Treatment of Childhood Malnutrition
Study Overview
Status
Conditions
Detailed Description
Rice bran is a nutrient dense food ingredient with prebiotics and phytochemicals, as well as vitamins, fatty acids, and amino acids. The investigators will determine if the inclusion of rice bran to locally produced RUTFs will improve SAM treatment for children in Indonesia. This will be assessed by standard anthropometric measures and determining the modulation of the malnourished child's gut microbiome and metabolome. The study will also assess rates of relapse in the entire cohort.
This study will yield new information of direct importance and impact to public health nutrition and advance our knowledge and treatment of SAM in Indonesia. Investigation of the gut-microbiota metabolism following consumption of rice bran provided in RUTFs compared to RUTF without rice bran included will provide key mechanistic insights for repairing nutrient absorptive functions in the gut, sustaining gut health in treated children and inform long-term treatment solutions for SAM.
Study Type
Enrollment (Estimated)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
East Java
-
Jember, East Java, Indonesia
- Savica
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Willing to participate in the study, with parent(s) signing the informed consent. If the caretaker denies the participation of the child, the child will be enrolled for treatment through the health system, but the information will be not considered for the purpose of the trial.
- Child identified with a weight-for-height z-score WHZ of < -2.5 (SAM children and children with advanced moderate acute malnutrition) and/or mid-upper arm circumference (MUAC) <115 mm) or a child with mild to moderate nutritional edema (regardless of anthropometry).
- Being qualified for outpatient treatment.
- Aged 6-59 months old upon enrolment
- Pass appetite test (taste test) (as stipulated by WHO guidelines on the treatment of SAM). See appetite test document attached.
- Not having consumed RUTF in the last two months
Exclusion Criteria:
- Children detected with severe acute malnutrition younger than 6 months of age will be excluded from the project, as well as any child with a body weight <4.0 kg.
- Children 6-59 months old who, when diagnosed with SAM, have been detected with medical complications, with TB, HIV positive status, one or more signs from the Integrated Management of Childhood Illness (IMCI) guidelines, severe oedema (+++) or who have failed the appetite test (see appetite test document attached).
- Medical complications include: Cough/difficulty in breathing; Diarrhea; Fever; Ear Problems. IMCI signs will be identified according to WHO definition and include not able to drink or breastfeed; vomiting; convulsions; lethargy.
- Participating in another clinical trial
- Any congenital disorder that interferes with normal nutrient intake; chronic conditions including but not exclusively disorders of heart, kidney or liver (children to be screened by a physician).
- SAM with complications requiring hospital treatment. (Upon discharge from hospital, the child will be re-evaluated for inclusion in the study).
- Siblings will not be allowed to participate in the trial
Withdrawal criteria:
- Not consuming the RUTF supplementation at all in >4 days a week in 2 consecutive weeks.
- Not providing samples or completing forms/questionnaires at study visits
- Developing medical complications requiring hospitalization
- Not gaining weight after 1 month of treatment
- Major reactions to intervention
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Ready-to-use therapeutic food, no rice bran (control/comparator)
Randomized participants will receive a locally produced ready-to-use therapeutic food to be consumed daily.
|
Children assigned to the active comparator group will be treated for severe acute malnutrition with a novel ready-to-use therapeutic food (no rice bran).
|
Experimental: Ready-to-use therapeutic food, with heat stabilized rice bran (Experimental)
Randomized participants will receive a locally produced ready-to-use therapeutic food with 5% heat stabilized rice bran to be consumed daily.
|
Children assigned to the experimental group will be treated for severe acute malnutrition with a novel ready-to-use therapeutic food that contains 5% heat stabilized rice bran.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Efficacy of the locally produced ready-to-use therapeutic food + heat stabilized rice bran as compared to locally produced ready-to-use therapeutic food alone in the treatment of severe acute malnutrition as determined by child weight.
Time Frame: Baseline, week 4, week 8, and week 16
|
This will be assessed by measures of: - Weight |
Baseline, week 4, week 8, and week 16
|
Efficacy of the locally produced ready-to-use therapeutic food + heat stabilized rice bran as compared to locally produced ready-to-use therapeutic food alone in the treatment of severe acute malnutrition as determined by mid-upper arm circumference.
Time Frame: Changes between baseline, week 4, week 8, and week 16
|
This will be assessed by measures of: -Mid-upper arm circumference |
Changes between baseline, week 4, week 8, and week 16
|
Efficacy of the locally produced ready-to-use therapeutic food + heat stabilized rice bran as compared to locally produced ready-to-use therapeutic food alone in the treatment of severe acute malnutrition as determined by morbidity.
Time Frame: Changes between baseline, week 4, week 8, and week 16
|
This will be assessed by measures of: - Morbidity (diarrhea, fever, vomiting, upper or lower respiratory infection) |
Changes between baseline, week 4, week 8, and week 16
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stool microbiota composition
Time Frame: Changes between baseline, week 4, week 8, and week 16
|
Determine stool microbiota composition of infants in both arms over time using 16S rRNA sequencing and shotgun metagenomic sequencing.
|
Changes between baseline, week 4, week 8, and week 16
|
Dried blood spot metabolite profile
Time Frame: Changes between baseline, week 4, week 8, and week 16
|
Dried blood spots will be analyzed for metabolites.
|
Changes between baseline, week 4, week 8, and week 16
|
Relapse
Time Frame: Week 16 (end of study)
|
Determine the number of participants that experience severe acute malnutrition relapse 4 weeks after the treatment/intervention has ended.
|
Week 16 (end of study)
|
Percent of children recovered
Time Frame: Baseline, week 4, week 8, and week 16
|
The number of children recovered in the 4 week treatment period will be determined as well as the time to recovery (days).
|
Baseline, week 4, week 8, and week 16
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Damayanti Soekarjo, PhD, Savica, Indonesia
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CSU IRB#:1823
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Severe Acute Malnutrition
-
Society for Applied StudiesWorld Health Organization; Christian Medical College, Vellore, India; ArthCompletedUncomplicated Severe Acute MalnutritionIndia
-
University of California, San FranciscoEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedUncomplicated Severe Acute MalnutritionBurkina Faso
-
International Centre for Diarrhoeal Disease Research...UNICEF; NutrisetCompletedSevere Acute Malnutrition in ChildhoodBangladesh
-
International Centre for Diarrhoeal Disease Research...UNICEFNot yet recruitingMalnutrition SevereBangladesh
-
UNICEFSave the ChildrenCompletedSevere MalnutritionCongo, The Democratic Republic of the
-
Aga Khan UniversityAction Contre la FaimCompletedEvaluation of the Effectiveness and Impact of Community Case Management of Severe Acute MalnutritionSevere MalnutritionPakistan
-
Action Against Hunger USAUniversity of Washington; Ethiopian Public Health InstituteNot yet recruitingModerate Acute Malnutrition | Severe Acute Malnutrition
-
Microbiome Health Research InstituteUniversity of Cape TownTerminatedModerate Acute Malnutrition | Severe Acute MalnutritionSouth Africa
-
University of OxfordLondon School of Hygiene and Tropical Medicine; University College, London; KEMRI-Wellcome... and other collaboratorsUnknownAntibiotic Resistance | Malnutrition Severe | Antibiotic ToxicityKenya, Uganda
-
Victor M. AguayoGandhi Medical College, Bhopal; Bundelkhand Medical College, Sagar, Madhya... and other collaboratorsCompletedSevere MalnutritionIndia
Clinical Trials on Ready-to-use therapeutic food (no rice bran)
-
International Rescue CommitteeMinistry of health, Mali; University of the Sciences, Techniques and Technologies...Active, not recruitingAcute Malnutrition in Childhood | Underweight | Acute Malnutrition in InfancyMali
-
Makerere UniversityNUFUUnknownMalnutritionNorway, Uganda
-
University of WashingtonLa Clinique des Maladies Infectieuses, Centre Hospitalier National Universitaire...CompletedHIV and Tuberculosis Co-infection
-
Infectious Diseases InstituteUniversity of Dublin, Trinity CollegeUnknown
-
UNICEF - VenezuelaTerminatedWasting | Acute Malnutrition in Childhood | Child MalnutritionVenezuela
-
International Centre for Diarrhoeal Disease Research...Washington University School of MedicineNot yet recruitingSevere Acute MalnutritionBangladesh
-
Alliance for International Medical ActionInstitut National de la Santé Et de la Recherche Médicale, France; Institut... and other collaboratorsCompletedGlobal Acute Malnutrition (GAM)Burkina Faso
-
Aga Khan UniversityUnited Nations World Food Programme (WFP); People's Primary Healthcare Initiative...WithdrawnSevere Acute MalnutritionPakistan
-
Institut de Recherche pour le DeveloppementUnited Nations World Food Programme (WFP); UNICEF; Sidaction; Global FundCompletedHIV/AIDS | Malnutrition
-
Institut de Recherche en Sciences de la Sante,...Bill and Melinda Gates Foundation; Ministry of Health, Burkina FasoNot yet recruitingAcute Malnutrition With no ComplicationsBurkina Faso